The first Acasti Pharma trade was made in Q2 2017.
Since then Ken Griffin bought shares nine more times and sold shares on eight occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in Acasti Pharma anymore.
Avg closing price
Price range
Sold -2.97 Thousand shares
Q4 2022
Avg closing price
$0.49
Price range
$0.34
-
$0.63
New holding (+2.97 Thousand shares)
Q3 2022
Avg closing price
$0.82
Price range
$0.56
-
$0.96
Sold -6.1 Thousand shares
Q4 2021
Avg closing price
$1.50
Price range
$1.07
-
$2.01
Increased shares by 163.9% (+3.79 Thousand shares)
Q3 2021
Avg closing price
$3.28
Price range
$1.96
-
$4.68
New holding (+2.31 Thousand shares)
Q2 2021
Avg closing price
$4.06
Price range
$3.24
-
$4.87
Sold -4.38 Thousand shares
Q3 2020
Avg closing price
$4.33
Price range
$1.52
-
$6.56
Increased shares by 191.4% (+2.88 Thousand shares)
Q2 2020
Avg closing price
$4.86
Price range
$2.64
-
$7.20
Increased shares by 204.3% (+1.01 Thousand shares)
Q1 2020